Privia Health Corp (PRVA) Kapitalizatsiyaning sof foydaga nisbati

Privia Health Group, Inc. (PRVA) brendining ramzi va logotipi

Privia Health Group o'z dasturiy ta'minotini ishlatish uchun uchinchi tomon bulutli xizmatlariga tayanadi. Kompaniyaning P/E koeffitsiyenti bozor baholashini namoyish etadi, bunda 89.10 ko'rsatkichi metrikaning holatini ifodalaydi. Biznes barqarorligi tibbiyot mutaxassislarini birlashtirishning tarmoq effekti va qat'iy HIPAA muvofiqligiga asoslangan. Samaradorlik avtomatlashtirilgan hisob-kitob algoritmlarini joriy etish va elektron sog'liqni saqlash yozuvlari tahlili orqali oshirilgan.

Privia Health (PRVA) - P/E multiplikatori 04.07.2022dan 12.11.2026gacha

Privia Health Corp (PRVA) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahlili:PRVA, priviahealth.com
Privia Health Group brendining mahsuloti

Privia Health Group (PRVA) ekotizimi xususiy shifokorlarni texnologik tarmoqqa integratsiya qiladi va tahliliy qo'llab-quvvatlash orqali ularga shifoxonalarga nisbatan raqobatbardosh ustunliklarni taqdim etadi. Kompaniyaga tegishli P/E dinamikasini tahlil qilish orqali investor ushbu biznes uchun nazorat premiumini aniqlaydi, chunki foydaga nisbatan narx ko'rsatkichi bozorning kelajakdagi o'sish uchun to'lov qilishga tayyorligini aks ettiradi, bu esa qadrsizlangan aktivlarni o'z vaqtida aniqlash yoki brend uchun haddan tashqari ko'p to'lash xavfini baholash imkonini beradi.

Raqobatdosh kompaniyalar

Narx-foyda multiplikatori VEEV (veeva.com)|Narxning foydaga nisbati Doximity (DOCS)|HQY: Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Waystar Inc. WAY|Kompaniya qiymatining sof foydaga nisbati CRVL|Huron Consulting Group - P/E multiplikatori|Biznesning o‘zini qoplash muddati certara.com CERT|OMCL (Omnicell) - Narx-foyda koeffitsiyenti|GDRX (GoodRx Inc) - Narxning foydaga nisbati|SDGR (Schrödinger Inc.) - P/E multiplikatori|Phreesia Health (PHR) - Biznesning o‘zini qoplash muddati|P/E multiplikatori OMDA|P/E multiplikatori evolenthealth.com (EVH)|HealthStream - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati DH|Consensus - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati AGL (Agilon Health Corp)|ABSI: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati soyoung.com (SY)|NRC (National Research Corporation) - P/E multiplikatori|P/E multiplikatori Spok Holdings Inc|Narxning foydaga nisbati OptimizeRx Corp. (OPRX)|Narxning foydaga nisbati TBRG (TruBridge Corp)|Simulations Plus, Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati SOPH (Sophia Genetics)|Health Catalyst - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati CCLD (CareCloud, Inc.)|RSSS (Research Solutions, Inc.) - Narx-foyda koeffitsiyenti|DLH Holdings - Kompaniya qiymatining sof foydaga nisbati|ONMD (OneMedNet Corp) - P/E multiplikatori|SCNX - Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti|Narxning foydaga nisbati Healthcare Triangle, Inc. (HCTI)|ISPC (ispecimen.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Bullfrog AI BFRG|SCWorx Inc (WORX) - Kapitalizatsiyaning foydaga nisbati|MSPR: Narx-foyda koeffitsiyenti|ICCT - P/E multiplikatori|TRxADE HEALTH (MEDS) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati ORGS (Orgenesis Inc)|Narxning foydaga nisbati R1 RCM, Inc.|Sharecare Inc - Kapitalizatsiyaning sof foydaga nisbati|Narxning foydaga nisbati Streamline Health Solutions (STRM)|SYRA (syrahealth.com) - Kompaniya qiymatining sof foydaga nisbati|Apollo Medical Holdings, Inc. - Narx-foyda koeffitsiyenti|Model N Inc - Narxning foydaga nisbati|NextGen - P/E multiplikatori